<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1 )*
CARRINGTON LABORATORIES, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, PAR VALUE $.01 PER SHARE
- --------------------------------------------------------------------------------
(Title of Class of Securities)
144525 10 2
---------------------------------------------------------
(CUSIP Number)
RUSSELL H. HARBAUGH, JR.
CONNER & WINTERS, A PROFESSIONAL CORPORATION
2400 FIRST PLACE TOWER, 15 EAST 5TH STREET
TULSA, OK 74103
(918) 586-5694
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
SEPTEMBER 19, 1996
---------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(b)(3) or (4), check the following
box [ ].
NOTE: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are
to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE>
SCHEDULE 13D
CUSIP NO. 144525 10 2 PAGE 2 OF 4 PAGES
----------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
JOHN T. OXLEY
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS
N/A
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
-0-
SHARES
-----------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY -0-
EACH -----------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
REPORTING
-0-
PERSON
-----------------------------------------------------------------
WITH 10 SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
-0-
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
- -------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
- --------------------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP NO. 144525 10 2 PAGE 3 OF 4 PAGES
----------------
SCHEDULE 13D STATEMENT
----------------------
This statement constitutes Amendment No. 1 to the Schedule 13D (the
"Schedule 13D") of Mr. John T. Oxley (the "Reporting Person") with respect to
the common stock, par value $.01 per share (the "Common Stock") of Carrington
Laboratories, Inc. (the "Issuer"). This Amendment No. 1 is being filed to
report the death of the Reporting Person on September 19, 1996.
ITEM 1. SECURITY AND ISSUER
---------------------------
This Schedule 13D relates to the Common Stock, par value $.01 per share
of the Issuer whose principal executive offices are located at 2001 Walnut
Hill Lane, Irving, Texas 75038.
ITEM 2. IDENTITY AND BACKGROUND
-------------------------------
(a) Name: John T. Oxley
(b) Business Address: One West 3rd Street
Williams Center Tower I
Suite 1305
Tulsa, OK 74103
(c) N/A
(d) N/A
(e) N/A
(f) N/A
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
---------------------------------------------------------
N/A
ITEM 4. PURPOSE OF TRANSACTION
------------------------------
N/A
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
--------------------------------------------
N/A
<PAGE>
SCHEDULE 13D
CUSIP NO. 144525 10 2 PAGE 4 OF 4 PAGES
----------------
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR
--------------------------------------------------
RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER
------------------------------------------------------
N/A
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
-----------------------------------------
N/A
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
THE JOHN T. OXLEY ESTATE
By: /s/ JOHN C. OXLEY
------------------------------------------
JOHN C. OXLEY, EXECUTOR
Date: FEBRUARY 20, 1997
